Literature DB >> 360223

Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis.

K M Das, R Dubin, T Nagai.   

Abstract

To determine if specific anticolon antibodies bound to colonic mucosa occur in ulcerative colitis, we obtained surgical specimens of colon from five patients with ulcerative colitis, one patient with diverticulitis, and three control subjects with carcinoma. Two specimens of ileum and cecum were also obtained from patients with Crohn ileocolitis. Tissue was homogenized and washed and bound Ig was eluted by citrate buffer, pH 3.2. Concentrated eluates of all specimens from patients with ulcerative colitis reacted with antisera to kappa and gamma and not with antisera to alpha and mu chains. Corresponding eluates from all other specimens did not react with these antisera, but did react with antialbumin. The presence of IgG in ulcerative colitis eluates was also determined by immunoelectrophoresis, immunocoprecipitation, and affinity chromatography with antisera against human IgG. Indirect immunofluorescence and uptake of radiolabeled antibody demonstrated antigenic sites in diseased colonic epithelium of biopsy specimens obtained from six additional patients with ulcerative colitis and three patients with idiopathic proctitis, but not in patients with Crohn disease, nonspecific diarrhea, and bacillary dysentery and control subjects. Although the role of colitis colon-bound antibody in the pathogenesis of ulcerative colitis is unclear, local antibody-antigen complexes may initiate colonic epithelial cytolysis by various immunologically mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360223      PMCID: PMC336149          DOI: 10.1073/pnas.75.9.4528

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The basement membranes of the epithelium of the colon and rectum in ulcerative colitis and other diseases.

Authors:  M A JACOBSON; J B KIRSNER
Journal:  Gastroenterology       Date:  1956-02       Impact factor: 22.682

2.  Immunohistochemical and electronmicroscopic observations on the local immune response in ulcerative colitis.

Authors:  J O Gebbers; H F Otto
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-07-11

3.  Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; D Campbell
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Circulating immune complexes in ulcerative colitis. I. Correlation to disease activity.

Authors:  H Nielsen; V Binder; H Daugharty; S E Svehag
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

6.  Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.

Authors:  J F Engstrom; C Arvanitakis; A Sagawa; N I Abdou
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

7.  Idiopathic proctitis. I. The morphology of proximal colonic mucosa and its clinical significance.

Authors:  K M Das; R Morecki; P Nair; J M Berkowitz
Journal:  Am J Dig Dis       Date:  1977-06

8.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

9.  In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

10.  Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

View more
  23 in total

1.  Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.

Authors:  Yoshio Jinno; Haruo Ohtani; Shiro Nakamura; Motoji Oki; Kiyoshi Maeda; Kohei Fukushima; Hiroshi Nagura; Nobuhide Oshitani; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Virchows Arch       Date:  2006-01-25       Impact factor: 4.064

Review 2.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

3.  Serological markers to differentiate between ulcerative colitis and Crohn's disease.

Authors:  M Oudkerk Pool; G Bouma; S G Meuwissen; B M von Blomberg; J P van de Merwe; W L Devillé; J C Fonk; A S Peña
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum.

Authors:  T Hassan; Y Kanisawa; S Meyers; A Dasgupta; K M Das
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

5.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

6.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease.

Authors:  T Hibi; M Ohara; K Kobayashi; W R Brown; K Toda; H Takaishi; Y Hosoda; A Hayashi; Y Iwao; M Watanabe
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.

Authors:  G Sieber; F Herrmann; M Zeitz; H Teichmann; H Rühl
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

8.  Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis.

Authors:  T Hibi; S Aiso; M Ishikawa; M Watanabe; T Yoshida; K Kobayashi; H Asakura; S Tsuru; M Tsuchiya
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

9.  Spontaneous suppressor cell function in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

10.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.